About VISIE
VISIE is a company based in Austin (United States) founded in 2017 by Aaron Bernstein and Patrick Edwards. VISIE has raised $12.71 million across 9 funding rounds from investors including Epilepsy Foundation, Capital Factory and Medingenii. VISIE offers products and services including 3D Spatial Computing Platform and 3D Scanners. VISIE operates in a competitive market with competitors including Caresyntax, Haemonetics, ClearPoint Neuro, Cydar Medical and Inscopix, among others.
- Headquarter Austin, United States
- Founders Aaron Bernstein, Patrick Edwards
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Visie Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.71 M (USD)
in 9 rounds
-
Latest Funding Round
$2.97 M (USD), Series A
Apr 30, 2025
-
Investors
Epilepsy Foundation
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VISIE
VISIE offers a comprehensive portfolio of products and services, including 3D Spatial Computing Platform and 3D Scanners.
Platform for 3D vision to enhance surgical accuracy and navigation.
Investigational tools for precise anatomical tracking in surgery.
Funding Insights of VISIE
VISIE has successfully raised a total of $12.71M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $2.97 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VISIE
VISIE has secured backing from 9 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Epilepsy Foundation, Capital Factory and Medingenii.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acceleration is provided to seed-stage, early-stage, and later-stage companies.
|
Locked | Locked | Locked | |
|
Medingenii is engaged in investing in healthcare innovation companies.
|
Locked | Locked | Locked | |
|
Cartmell Ventures is focused on early-stage health IT investments.
|
Locked | Locked | Locked |
Investor details for VISIE
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VISIE
Investment portfolio details for VISIE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VISIE
Detailed financials for VISIE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Visie Comparisons
Peer comparison for VISIE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VISIE
VISIE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Caresyntax, Haemonetics, ClearPoint Neuro, Cydar Medical and Inscopix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Surgical outcomes are enhanced via analytics and integration platform.
|
|
| Locked | Locked | Locked |
Hematology products and solutions are provided for medical applications.
|
|
| Locked | Locked | Locked |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| Locked | Locked | Locked |
Surgical images are analyzed via AI for endovascular procedures.
|
|
| Locked | Locked | Locked |
Miniscope platforms are developed for decoding brain neural circuits.
|
|
| Locked | Locked | Locked |
Solutions for image-guided interventional procedures are developed.
|
Detailed competitors of VISIE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Visie
Complete news archive for VISIE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VISIE
VISIE was founded in 2017 and raised its 1st funding round 1 year after it was founded.
VISIE is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Douglas Fairbanks Fairbanks is the current CEO of VISIE.
VISIE is a funded company, having raised a total of $12.71M across 9 funding rounds to date.
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery. The companys proprietary maging hardware combines the power of science and deep tech to develop intraoperative scanners to streamline surgeries in the operating room.
VISIE's top competitors include Caresyntax, ClearPoint Neuro and Haemonetics.
VISIE offers 3D Spatial Computing Platform and 3D Scanners.
VISIE has 9 investors. Key investors include Epilepsy Foundation, Capital Factory, Medingenii, Cartmell Ventures, and Flat Rock Global.